Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Brain-gut Axis in Inflammatory Bowel Diseases: Implementation and Exploration of Mechanism and Early Effectiveness of a Mindfulness-based Stress Reduction Program

NCT07266883 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT07266883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07266883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Brain-gut Axis in Inflammatory Bowel Diseases: Implementation and Exploration of Mechanism and Early Effectiveness of a Mindfulness-based Stress Reduction Program
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2027
Completion date
February 1, 2028
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease (crohn's disease and ulcerative colitis)